CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishAim: reactive oxigen species (ROS) have a well-estabilished role in the athogenesis of many forms of malignancy and superoxide dismutase(SODs) are the only enzymes dismuting one of the main radicals: the superoxide anion. Since many human tumors have shown significant changes in the activity and expression of SODs, this enzyme might be correlated with survival and clinical-pathological parameters for the prognosis of human carcinoma. This preliminary study were performed to assess the SODs(CuZnSOD and MnSOD) activity and expression in gastric adenocarcinoma with respect to healthy tissue using western blotting (W-B) technique as a specific and sensible clinical test.
| Titolo: | Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. | |
| Autore/i: | MONARI, MARTA; CATTANI, OTELLO; J. Foschi; TUGNOLI, VITALIANO; M. R. Tosi; C. Calabrese; A. Fabbri; D. Zahlane; M. Miglioli; DI FEBO, GIULIO; TRINCHERO, ANDREA | |
| Autore/i Unibo: | ||
| Anno: | 2005 | |
| Titolo del libro: | Digestive Disease Week 2005 | |
| Pagina iniziale: | . | |
| Pagina finale: | . | |
| Abstract: | Aim: reactive oxigen species (ROS) have a well-estabilished role in the athogenesis of many forms of malignancy and superoxide dismutase(SODs) are the only enzymes dismuting one of the main radicals: the superoxide anion. Since many human tumors have shown significant changes in the activity and expression of SODs, this enzyme might be correlated with survival and clinical-pathological parameters for the prognosis of human carcinoma. This preliminary study were performed to assess the SODs(CuZnSOD and MnSOD) activity and expression in gastric adenocarcinoma with respect to healthy tissue using western blotting (W-B) technique as a specific and sensible clinical test. | |
| Data prodotto definitivo in UGOV: | 13-ott-2005 | |
| Appare nelle tipologie: | 4.02 Riassunto (Abstract) |
File in questo prodotto:
Copyright © 2022